Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, WuXi XDC Cayman's Enterprise Value is HK$82,850 Mil.
WuXi XDC Cayman's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2,101 Mil. Therefore, WuXi XDC Cayman's EV-to-EBIT ratio for today is 39.44.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, WuXi XDC Cayman's Enterprise Value is HK$82,850 Mil.
WuXi XDC Cayman's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2,101 Mil. Therefore, WuXi XDC Cayman's EV-to-EBITDA ratio for today is 39.44.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, WuXi XDC Cayman's Enterprise Value is HK$82,850 Mil.
WuXi XDC Cayman's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$7,864 Mil. Therefore, WuXi XDC Cayman's EV-to-Revenue ratio for today is 10.53.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, WuXi XDC Cayman's Enterprise Value is HK$82,850 Mil.
WuXi XDC Cayman's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$579 Mil. Therefore, WuXi XDC Cayman's EV-to-FCF ratio for today is 143.09.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
WuXi XDC Cayman (HKSE:02268) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
WuXi XDC Cayman's current Enterprise Value is HK$82,850 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2,101 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
WuXi XDC Cayman's current Enterprise Value is HK$82,850 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2,101 Mil.
WuXi XDC Cayman's current Enterprise Value is HK$82,850 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$7,864 Mil.
WuXi XDC Cayman's current Enterprise Value is HK$82,850 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1,963 Mil.
WuXi XDC Cayman's current Enterprise Value is HK$82,850 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$579 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WuXi XDC Cayman Enterprise Value Related Terms
WuXi XDC Cayman Enterprise Value Historical Data
* Premium members only.
The historical data trend for WuXi XDC Cayman's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02268 vs TMO, DHR, NTRA: Enterprise Value Comparison
For the Diagnostics & Research subindustry, WuXi XDC Cayman's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WuXi XDC Cayman Enterprise Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Enterprise Value distribution charts can be found below:
* The bar in red indicates where WuXi XDC Cayman's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
WuXi XDC Cayman's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$82,850 Mil mean?
WuXi XDC Cayman (HKSE:02268) has a Enterprise Value of HK$82,850 Mil as of Sep. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on WuXi XDC Cayman and its competitors.
Is WuXi XDC Cayman's Enterprise Value too high?
WuXi XDC Cayman's current Enterprise Value is HK$82,850 Mil. Overall, WuXi XDC Cayman has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does WuXi XDC Cayman's Enterprise Value compare to TMO and DHR?
WuXi XDC Cayman's Enterprise Value of HK$82,850 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on WuXi XDC Cayman and its competitors. WuXi XDC Cayman's current Enterprise Value is HK$82,850 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi XDC Cayman stock overvalued right now?
WuXi XDC Cayman (HKSE:02268) has a current Enterprise Value of HK$82,850 Mil. The current Enterprise Value is HK$82,850 Mil. WuXi XDC Cayman's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For WuXi XDC Cayman (HKSE:02268), the current Enterprise Value is HK$82,850 Mil as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.
50GF Score
Get the complete analysis for HKSE:02268
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02268 has been successfully added to your 
